Dr. Reddy’s Laboratories Ltd ADR (RDY) Stock Forecast
Alert
Its only available to paid users.
N/A
Based on the Dr. Reddy’s Laboratories Ltd ADR stock forecast from 0 analysts, the average analyst target price for Dr. Reddy’s Laboratories Ltd ADR is not available over the next 12 months. Dr. Reddy’s Laboratories Ltd ADR’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Dr. Reddy’s Laboratories Ltd ADR is Bullish , which is based on 10 positive signals and 2 negative signals. At the last closing, Dr. Reddy’s Laboratories Ltd ADR’s stock price was USD 15.37. Dr. Reddy’s Laboratories Ltd ADR’s stock price has changed by +6.29% over the past week, +9.86% over the past month and +15.03% over the last year.
No recent analyst target price found for Dr. Reddy’s Laboratories Ltd ADR
No recent average analyst rating found for Dr. Reddy’s Laboratories Ltd ADR
Company Overview Dr. Reddy’s Laboratories Ltd ADR
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segments. The company's Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations, as well as engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids in accordance with the specific customer requirements. The Others segment engages in developing therapies in the fields of oncology and inflammation; research and development of differentiated formulations; and provides digital healthcare and information technology enabled business support services. The company offers its products for various therapeutic categories primarily include gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India. Read Less
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segments. The company's Global Generics segment man...Read More
Frequently Asked Questions About Dr. Reddy’s Laboratories Ltd ADR (RDY) Stock
Stock Target Advisor's fundamental analysis for Dr. Reddy’s Laboratories Ltd ADR's stock is Bullish .
RDY stock's dividend yield is 0.67%.
Our analysis grades RDY stock's dividend yield at F. This means that RDY stock's dividend yield is above 25% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the NYE exchange.
Based on this RDY may be a poor dividend stock for its sector.
Unfortunately we do not have enough data on RDY's stock to indicate what its average analyst target is.
RDY stock's Price/Earning ratio is 18.13.
Our analysis grades RDY stock's Price / Earning ratio at B+. This means that RDY stock's Price/Earning ratio is above 11% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the NYE exchange.
Based on this RDY may be undervalued for its sector.
The last closing price of RDY's stock was USD 15.37.
The most recent market capitalization for RDY is USD 11.86B.
Unfortunately we do not have enough analyst data on RDY's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Dr. Reddy’s Laboratories Ltd ADR's stock.
As per our most recent records Dr. Reddy’s Laboratories Ltd ADR has 27,048 Employees.
Dr. Reddy’s Laboratories Ltd ADR's registered address is 8-2-337, Road No. 3, Hyderabad, India, 500034.
You can get more information about it from Dr. Reddy’s Laboratories Ltd ADR's website at https://www.drreddys.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low debt
The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
Underpriced compared to earnings
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Low Dividend Growth
This stock has shown below median dividend growth in the previous 5 years compared to its sector.
Frequently Asked Questions About Dr. Reddy’s Laboratories Ltd ADR (RDY) Stock
Stock Target Advisor's fundamental analysis for Dr. Reddy’s Laboratories Ltd ADR's stock is Bullish .
RDY stock's dividend yield is 0.67%.
Our analysis grades RDY stock's dividend yield at F. This means that RDY stock's dividend yield is above 25% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the NYE exchange.
Based on this RDY may be a poor dividend stock for its sector.
Unfortunately we do not have enough data on RDY's stock to indicate what its average analyst target is.
RDY stock's Price/Earning ratio is 18.13.
Our analysis grades RDY stock's Price / Earning ratio at B+. This means that RDY stock's Price/Earning ratio is above 11% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the NYE exchange.
Based on this RDY may be undervalued for its sector.
The last closing price of RDY's stock was USD 15.37.
The most recent market capitalization for RDY is USD 11.86B.
Unfortunately we do not have enough analyst data on RDY's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Dr. Reddy’s Laboratories Ltd ADR's stock.
As per our most recent records Dr. Reddy’s Laboratories Ltd ADR has 27,048 Employees.
Dr. Reddy’s Laboratories Ltd ADR's registered address is 8-2-337, Road No. 3, Hyderabad, India, 500034.
You can get more information about it from Dr. Reddy’s Laboratories Ltd ADR's website at https://www.drreddys.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for RDY !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
